Michael Lichtenauer

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski, Ewald Kolesnik, Norbert J. Tripolt et al. · European Heart Journal · 2022 · 290 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy

Can Gollmann‐Tepeköylü, Michael Graber, Jakob Hirsch et al. · Cardiovascular Research · 2019 · 108 citations · Full text

Life Sciences, Cardiology, Cell Biology +17

Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial

Norbert J. Tripolt, Ewald Kolesnik, Peter N. Pferschy et al. · American Heart Journal · 2019 · 72 citations

Medicine, Cardiology, Pharmacology +15

Admission Body Temperature in Critically Ill Patients as an Independent Risk Predictor for Overall Outcome

Ralf Erkens, Bernhard Wernly, Maryna Masyuk et al. · Medical Principles and Practice · 2019 · 48 citations · Full text

Medicine, Internal Medicine, Critical Care Cardiology +9

Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury

Bernhard Wernly, Georg Fuernau, Maryna Masyuk et al. · Scientific Reports · 2019 · 45 citations · Full text

Medicine, Cardiology, Internal Medicine +16